Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Ève Hamelin

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Pathogens (Basel, Switzerland)|February 26, 2020
Engineering of Live Chimeric Vaccines against Human MetapneumovirusDaniela Ogonczyk Makowska, Marie-Ève Hamelin, Guy Boivin
The Journal of General Virology|November 21, 2007
Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virusMarie-Ève Hamelin, Christian Couture, Melanie K Sackett, et al.
Clinical Microbiology Reviews|July 10, 2026
Twenty-five years of human metapneumovirus researchElhadji Birane Mboup, Julia Dubois, Marie-Ève Hamelin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 1, 2011
Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011Julie Ann, Jesse Papenburg, Xavier Bouhy, et al.
Vaccines|June 27, 2025
Vaccine Development for Human PneumovirusesElhadji Birane Mboup, Marie-Ève Hamelin, Julia Dubois, et al.
The Journal of General Virology|December 19, 2014
Adjuvant effect of the human metapneumovirus (HMPV) matrix protein in HMPV subunit vaccinesLaetitia Aerts, Chantal Rhéaume, Julie Carbonneau, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 2, 2014
Human metapneumovirus viral load is an important risk factor for disease severity in young childrenJean-François Roussy, Julie Carbonneau, Manale Ouakki, et al.
Vaccine|April 16, 2013
Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in miceCamille Lévy, Laetitia Aerts, Marie-Ève Hamelin, et al.
The Journal of General Virology|August 14, 2018
Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in miceBa Vuong Lê, Martine Jandrot-Perrus, Christian Couture, et al.
Antimicrobial Agents and Chemotherapy|August 13, 2014
Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected miceAndrés Pizzorno, Yacine Abed, Pier-Luc Plante, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Pathogens (Basel, Switzerland)|February 26, 2020
Engineering of Live Chimeric Vaccines against Human MetapneumovirusDaniela Ogonczyk Makowska, Marie-Ève Hamelin, Guy Boivin
The Journal of General Virology|November 21, 2007
Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virusMarie-Ève Hamelin, Christian Couture, Melanie K Sackett, et al.
Clinical Microbiology Reviews|July 10, 2026
Twenty-five years of human metapneumovirus researchElhadji Birane Mboup, Julia Dubois, Marie-Ève Hamelin, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|November 1, 2011
Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011Julie Ann, Jesse Papenburg, Xavier Bouhy, et al.
Vaccines|June 27, 2025
Vaccine Development for Human PneumovirusesElhadji Birane Mboup, Marie-Ève Hamelin, Julia Dubois, et al.
The Journal of General Virology|December 19, 2014
Adjuvant effect of the human metapneumovirus (HMPV) matrix protein in HMPV subunit vaccinesLaetitia Aerts, Chantal Rhéaume, Julie Carbonneau, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 2, 2014
Human metapneumovirus viral load is an important risk factor for disease severity in young childrenJean-François Roussy, Julie Carbonneau, Manale Ouakki, et al.
Vaccine|April 16, 2013
Virus-like particle vaccine induces cross-protection against human metapneumovirus infections in miceCamille Lévy, Laetitia Aerts, Marie-Ève Hamelin, et al.
The Journal of General Virology|August 14, 2018
Evaluation of anticoagulant agents for the treatment of human metapneumovirus infection in miceBa Vuong Lê, Martine Jandrot-Perrus, Christian Couture, et al.
Antimicrobial Agents and Chemotherapy|August 13, 2014
Evolution of oseltamivir resistance mutations in Influenza A(H1N1) and A(H3N2) viruses during selection in experimentally infected miceAndrés Pizzorno, Yacine Abed, Pier-Luc Plante, et al.
Pageof 4